Pharmacy

Department of Health written question – answered on 11th September 2017.

Alert me about debates like this

Photo of Jon Ashworth Jon Ashworth Shadow Secretary of State for Health

To ask the Secretary of State for Health, what the projected costs are for the Pharmacy Access Scheme in each quarter up to March 2018.

Photo of Jon Ashworth Jon Ashworth Shadow Secretary of State for Health

To ask the Secretary of State for Health, what assessment he has made of the efficacy of the Pharmacy Access Scheme; and if he will make a statement.

Photo of Jon Ashworth Jon Ashworth Shadow Secretary of State for Health

To ask the Secretary of State for Health, how much funding was allocated to community pharmacies through the Pharmacy Access Scheme in 2016-17 by local authority area.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary of State for Health

Services under the community pharmacy contractual framework, including the Pharmacy Access Scheme (PhAS), are commissioned and funded by the National Health Service, rather than local authorities. The projected costs for the PhAS in 2016/17 and 2017/18, for December 2016 and then in each quarter up to March 2018, are given below:

December 2016

January 2017 - March 2017

April 2017 - June 2017

July 2017 - September 2017

October 2017 - December 2017

January 2018 - March 2018

PhAS (£)

3,960,069

11,880,206

5,812,669

5,812,669

5,812,669

5,812,669

PhAS reviews* (£)

123,529

370,587

240,809

240,809

240,809

240,809

Total (£)

4,083,598

12,250,793

6,053,478

6,053,478

6,053,478

6,053,478

*These figures showing the cost of additional pharmacies being granted the PhAS through the review process are subject to update. They do not include pharmacies operating under local pharmaceutical services contracts, which return to the pharmaceutical list and are eligible for the scheme.

The community pharmacy funding package, implemented from 1 December 2016, is delivering significant savings - £113 million in 2016/17 and a further £208 million in 2017/18 – and making an important contribution to the £22 billion NHS efficiency savings. The PhAS is a key element of that funding package to support access where pharmacies are sparsely spread and patients depend on them most.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.